|
NAMPT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.799600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.936030E-01 |
| Normal-vs-Stage2 |
4.175600E-02 |
| Normal-vs-Stage3 |
1.053220E-01 |
| Normal-vs-Stage4 |
1.400250E-02 |
| Stage1-vs-Stage2 |
1.454410E-01 |
| Stage1-vs-Stage3 |
3.682200E-01 |
| Stage1-vs-Stage4 |
5.268000E-02 |
| Stage2-vs-Stage3 |
7.639200E-01 |
| Stage2-vs-Stage4 |
4.731600E-01 |
| Stage3-vs-Stage4 |
3.428200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.033600E-02 |
| Normal-vs-AfricanAmerican |
7.822600E-01 |
| Normal-vs-Asian |
3.172000E-01 |
| Caucasian-vs-AfricanAmerican |
3.722000E-02 |
| Caucasian-vs-Asian |
1.127650E-02 |
| AfricanAmerican-vs-Asian |
4.251000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.065700E-02 |
| Normal-vs-Female |
2.311600E-01 |
| Male-vs-Female |
1.996350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.558400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.178000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.638100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.279400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.131800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.315800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.178000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.540000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.447800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.656400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.002000E-01 |
| Normal-vs-Grade 2 |
3.604000E-02 |
| Normal-vs-Grade 3 |
2.786800E-01 |
| Normal-vs-Grade 4 |
9.020400E-03 |
| Grade 1-vs-Grade 2 |
2.451600E-02 |
| Grade 1-vs-Grade 3 |
1.869450E-01 |
| Grade 1-vs-Grade 4 |
6.057900E-03 |
| Grade 2-vs-Grade 3 |
1.363980E-01 |
| Grade 2-vs-Grade 4 |
2.437400E-01 |
| Grade 3-vs-Grade 4 |
3.037900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.515200E-01 |
| Normal-vs-ccB subtype |
2.762500E-03 |
| ccA subtype-vs-ccB subtype |
2.498500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.151900E-02 |
| Normal-vs-N1 |
1.233410E-01 |
| N0-vs-N1 |
2.212200E-01 |
|
|
